Key statistics
As of last trade Jazz Pharmaceuticals PLC (J7Z:FRA) traded at 125.05, -10.39% below its 52-week high of 139.55, set on Feb 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 122.65 |
---|---|
High | 125.85 |
Low | 122.65 |
Bid | 125.05 |
Offer | 125.65 |
Previous close | 123.00 |
Average volume | 250.67 |
---|---|
Shares outstanding | 60.45m |
Free float | 58.68m |
P/E (TTM) | 16.94 |
Market cap | 7.27bn USD |
EPS (TTM) | 7.10 USD |
Data delayed at least 15 minutes, as of Mar 13 2025 18:55 BST.
More ▼
Press releases
- Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
- Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
- Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance
- Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance
- Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
- Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
- Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
- Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
- Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
More ▼